Association of Body Mass Index With the Safety Profile of Nivolumab With or Without Ipilimumab

IMPORTANCE: Increased survival with immune checkpoint inhibitors has been reported for patients with obesity vs a normal body mass index (BMI). However, the association of obesity with the safety of immune checkpoint inhibitors warrants study. OBJECTIVE: To investigate associations between BMI and i...

Descripción completa

Detalles Bibliográficos
Autores principales: McQuade, Jennifer L., Hammers, Hans, Furberg, Helena, Engert, Andreas, André, Thierry, Blumenschein, George, Tannir, Nizar, Baron, Ari, Larkin, James, El-Khoueiry, Anthony, Carbone, David P., Thomas, John-Michael, Hennicken, Delphine, Coffey, Mary, Motzer, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857666/
https://www.ncbi.nlm.nih.gov/pubmed/36480191
http://dx.doi.org/10.1001/jamaoncol.2022.5409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9857666/
https://www.ncbi.nlm.nih.gov/pubmed/36480191
http://dx.doi.org/10.1001/jamaoncol.2022.5409

Ejemplares similares